By staying on this site, you agree to this basic condition. We would like to draw your attention to the fact that if you use any information you learn here in practice, you do so at your own risk. All medicines on the market are thus produced without the consent of Gilead and come from the Chinese market. Given that the owner of the Gilead Sciences patent is not interested in launching GS-441524, and especially in the case of Covid-19, he preferred Remdesivir, it is very questionable when and if at all in the foreseeable future we will receive legal treatment with GS-441524. In addition, Anivive is working to approve a protease inhibitor called GC376which was the subject of clinical study for the treatment of FIP as early as 2016 and proved to be effective mainly in the treatment of wet and dry FIP without eyepieces and neurological symptoms. Although no clinical trial has been performed to treat FIP, it has been used many times in practice and its efficacy is evident. And, of course, there is an overview of drugs.Īt the end of 2021, a drug was approved for the treatment of Covid-19 Molnupiravir, sold in the Czech Republic and Slovakia under the trade name Lagevrio. You can also read here 96 articles, translated into Slovak from foreign press. On this website you will find a lot of information about FIP, but also its diagnosis and treatment. So the stories of the FIP warriors began to be written, which finally began to win over the disease. As a result, its efficacy in the treatment of this dreaded disease was clearly confirmed. In 2017 there took place at UC Davis under his leadership field trials using a new substance, which at that time was still known as EVO984. The discovery of FIP treatment was the culmination of 50 years of research of Dr. The hope for rescue came with an nucleoside analog GS-441524 developed by Gilead Sciences, where the GS code name comes from.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |